Altered production of IFN-gamma and other inflammation-related cytokines by mycobacteria-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients

Cellular and Molecular Biology

Volumn 52, Issue 1, 2006, Pages 59-64

  Rondelli, F M ^a   Mahuad, C V ^a   Gentiletti, A ^a   Goni M ^a   Pons Estel, B ^a   Bottasso, O ^a   Stanford, J L ^b   Bay, M L ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cytokine; Dysregulation; Mycobacteria; Rheumatoid Arthritis

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MITOGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIMENTAL INFECTION; FEMALE; FUNGUS ISOLATION; HUMAN; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INCUBATION TIME; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; RHEUMATOID ARTHRITIS; SEROTYPE;

ADULT; ARTHRITIS, RHEUMATOID; CANDIDA ALBICANS; CYTOKINES; EPITOPES; FEMALE; HUMANS; INFECTIOUS MONONUCLEOSIS; INFLAMMATION; INTERFERON TYPE II; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS; MYCOBACTERIACEAE; T-LYMPHOCYTES;

CANDIDA ALBICANS; CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 33745229990     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bahr, G.M., Rook, G.A., Al-Saffar, M., Van Embden, J., Stanford, J.L. and Behbehani, K., Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin. Exp. Immunol. 1988, 74: 211-215.
2. Bahr G.M., Sattar, M.I., Stanford, J.L., Shaaban, M.A., Al Shimali, B., Siddiqui, Z., Gabriel, M., Al Saffar, M., Shahin, A., Chugh, T.D., Rook, G.A.W. and Behbehani, K., HLA-DR and tuberculin tests in rheumatoid arthritis and tuberculosis. Ann. Rheum. Dis. 1998, 48: 63-68.
3. th Edition, John Wright and Co., Bristol and Simpkin, Marshall, Hamilton, Kent and Co. Ltd., London, 1906, 14-97.
4. Bay, M.L., Lehrer, A., Bressanelli, A., Morini, J., Bottasso, O. and Stanford, J., Psoriasis patients have T-cells with reduced responsiveness to common mycobacterial antigens. FEMS Immunol. Med. Microbiol. 1998, 21: 65-70.
5. Berthelot, J.M.and Maugars, Y., Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses. Joint Bone Spine 2004, 71: 374-380.
6. Billiau, A. and Matthys, P., Modes of action of Freund's adjuvants in experimental models of autoimmune diseases J. Leuk. Biol. 2001, 70: 849-860.
7. Chirico, C., Kuriger, A., Fernández, H. and Morcillo, N., Tuberculosis in the V Sanitary Zone of Buenos Aires Province. Analysis of its trends between 1984 and 1996. Medicina (Buenos Aires) 1999, 59: 332-338.
8. Cunnane, G., Breshnihan, M. and Fitzgerald, O., Immunohistologic analysis of peripheral joint disease in Ankylosing spondylitis. Arthritis Rheum. 1998, 41: 180-182.
9. Der Simonian, K., Sugita, M., Glass, D.N., Maier, A.L., Weinblatt, M.E., Reme, T. and Brenner, M.B., Clonal V alpha 12. 1+ T cell expansions in the peripheral blood of rheumatoid arthritis. J. Exp. Med. 1993, 177: 1623-1631.
10. Dlugovitzky, D., Torres, A., Hourquescos, M.C., Svetaz, M.J., Quagliato, N., Valentini, E., Amigot, B., Molteni, O. and Bottasso, O., Low occurrence of arthritic manifestations in patients with pulmonary tuberculosis. T cell subsets and humoral studies. Mem. Inst. Oswaldo Cruz 1995, 90: 623-628.
11. Eane, J. K., Gershon, S., Wise, R. P., Mirabile-Levens, E., Asznica, J. K., Schwieterman, W.D., Siegel, J.N. and Miles Braun, M., Tuberculosis associated with infliximab, a tumor necrosis factor α - neutralizing agent. N. Engl. J. Med. 2001, 345: 1098-1104.
12. Fitzgerald, J.E., Ricalton, N.S., Meyer, A.C., West, S.G., Kaplan, H., Behrendt, C. and Kotzin, B.L., Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 1995, 154: 3538-3547.
13. 15N]nitrate in biological fluids. Ann. Biochem. 1982, 126: 131-138.
14. Keitel, W., Wille, R., Franke, A and Ziegeler, J., Adjuvant arthritis in mice and hamsters. Acta Rheumatol. Scand. 1971, 17: 31-34.
15. Khoo, S.H., Wilkins, E.G., Fraser, I.S., Hamour, A.A. and Stanford, J.L., Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts. Thorax 1996, 51: 932-935.
16. Kogure, T., Fuginaga, H. and Niizawa, A., Rheumatoid arthritis complicated by Mycobacterium tuberculosis. Are there characteristics predisposing to this association? J. Clin. Rheumatol. 1999, 5: 17-21.
17. Kogure, T., Niizawa, A., Hai, L.X., Fujinaga, H., Shimada, Y., Ochiai, H. and Terasawa, K., Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2001, 60: 166-169.
18. Leipe, J., Skapenko, A., Lipsky, P.E. and Schulze-Koops, H., Regulatory T cells in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7: 93.
19. Palmero, D., Ritacco, V., Ambroggi, M., Natiello, M., Barrera, L., Capone, L., Dambrosi, A., Di Lonardo, M., Isola, N., Poggi, S., Vescovo, M. and Abbate, E., Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, Argentina. Emerging Infect. Dis. 2003, 9: 965-969.
20. Ramu, G. and Balakrishnan, S., Arthritis in lepromatous leprosy: clinical features and biochemical findings. Lepr. India 1968, 40: 62-69.
21. Rook, G.A.W. and Al-Attiyah, R., Cytokines and the Koch phenomenon. Tubercle 1991, 72: 13-20.
22. Rook, G.A.W. and Stanford, J.L., Slow bacterial infections or autoimmunity? Immunol. Today 1992, 13: 160-164.
23. Rook, G.A.W. and Stanford, J.L., Give us this day our daily germs. Immunol. Today 1998, 19: 113-116.
24. Schaller, J.G., Sharp, R.L., Wilder, R.L. and Hunder, G.G., The American Rheumatism Association 1987 revised of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.
25. Shield, M.J., Stanford, J.L., Paul, R.C. and Carswell, J.W., Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection. J. Hyg. (Cambridge) 1977, 78: 331-348.
26. Shield, M.J., Stanford, J.L., Garbajosa, G., Draper, P. and Rees, R.J.W., The epidemiological evaluation in Burma, of the skin test reagent LRA6; a cell-free extract from armadillo-derived Mycobacterium leprae. Part 1: Leprosy patients. Int. J. Lepr. 1982, 50: 436-445.
27. Shoenfeld, Y. and Isenberg, D.A., Mycobacteria and autoimmunity. Immunol. Today 1988, 9: 178-182.
28. Smeets, T.J.M., Dolhain, R.J.E.M., Miltenburg, A.M.M., de Kuiper, R., Breedveld, F.C. P. and Tak, P., Poor expression of T-cell derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. Clin. Immunol. Immunopathol. 1998, 88: 84-90.
29. Sood, R., Wali, J.P. and Handa, R., Poncet's disease in a north Indian hospital. Tropical Doctor 1999, 29: 33-36.
30. Stanford, J.L. and Grange, J.M., The meaning and structure of species as applied to mycobacteria. Tubercle 1974, 55: 143-152.
31. Stanford, J.L., Shield, M.J. and Rook, G.A.W., How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 1981, 62: 55-62.
32. Stanford, J.L. and Rook, G.A.W., Environmental mycobacteria and immunisation with BCG. In: Medical microbiology. Easmon, C.S.F. and Jeljaszewicz, J. (eds.), Acad. Press, New York, 1983, Vol. 2: 43-69.
33. Stanford, J.L., Stanford, C.A. and Grange, J.M., Environmental echoes. Science Progress 2001, 84: 105-124.
34. Thompson, S.J., Butcher, P.D., Patel, V.K.R., Rook, G.A.W., Stanford, J.L., Van der Zee R. and Elson, C.J., Modulation of pristane-induced arthritis by mycobacterial antigens. Autoimmunity 1991, 11: 35-43.
35. Toivanen, P. and Toivanen, A., The effect of epsilon-aminocaproic acid on adjuvant arthritis in rats. Experientia 1964, 20: 579-580.
36. Toussirot, E.A., Oral tolerance in the treatment of rheumatoid arthritis. Curr. Drug Targets Inflamm. Allergy 2002, 1: 45-52.
37. Tsoulfa, G., Rook, G.A.W., Bahr, G.M., Sattar, M.A., Behbehani, K., Young, D.B., Mehlert, A., van Embden, J.D.A., Hay, F.C., Isenberg, D.A. and Lydyard, P.M., Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand. J. Immunol. 1989, 30: 519-528.
38. Van der Brink, H.R., van der Heide, A., Jacobs, J.W., van der Veen, M.J. and Bijlsma, J.W., Evaluation of the Thompson articular index. J. Rheumatol. 1993, 20: 28-32.
39. Van der Graaff, W.L., Prins, A.P.A., Dijmans, B.A.C. and van Lie, R.A.W., Prognostic value of Th1/Th2 ratios in rheumatoid arthritis. Lancet 1998, 351: 1931.
40. Van Roon, J.A., Verhoef, C.M., van Roy, J.L., Gmelig-Meyling, F.H., Huber-Bruning, O., Lafeber, F.P. and Bijlsma, J.W., Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann. Rheum. Dis. 1997, 56: 656-660.
41. Vilagut, L., Pares, A., Vinas, O., Vila, J., Jimenez de Anta, M.T. and Rodes, J., Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur. J. Clin. Invest. 1997, 27: 667-672.
42. Weyand, C.M. and Goronzy, J.J., The molecular basis of rheumatoid arthritis. J. Mol. Med. 1997, 75: 772-785.
43. Young, D.B., Mehlert, A., Bal, V., Mendez-Samperio, P., Ivanyi, J. and Lamb, J.R., Stress proteins and the immune response to mycobacterial-antigens as virulence factors? Anton. Leeuw. Int. J. G. 1988, 54: 431-439.